Letter: Demonstration of reovirus-like particles in intestinal contents of piglets with diarrhoea.

Suzanne M. Rodger,J. Craven,I. Williams

DOI: https://doi.org/10.1111/J.1751-0813.1975.TB06917.X

1975-11-01

Australian Veterinary Journal

Abstract:

What problem does this paper attempt to address?

Nitric Oxide Releasing Hydrogel Promotes Endothelial Differentiation of Mouse Embryonic Stem Cells

Yan Nie,Kaiyue Zhang,Shuaiqiang Zhang,Dan Wang,Zhibo Han,Yongzhe Che,Deling Kong,Qiang Zhao,Zhongchao Han,Zuo-Xiang He,Na Liu,Fengxia Ma,Zongjin Li

DOI: https://doi.org/10.1016/j.actbio.2017.08.037

IF: 10.633

2017-01-01

Acta Biomaterialia

Abstract:Transplantation of endothelial cells (ECs) holds great promise for treating various kinds of ischemic diseases. However, the major challenge in ECs-based therapy in clinical applications is to provide high quality and enough amounts of cells. In this study, we developed a simple and efficient system to direct endothelial differentiation of mouse embryonic stem cells (ESCs) using a controllable chitosan nitric oxide (NO)-releasing hydrogel (CS-NO). ESCs were plated onto the hydrogel culture system, and the expressions of differentiation markers were measured. We found that the expression of Flk-1 (early ECs marker) and VE-cadherin (mature ECs marker) increased obviously under the controlled NO releasing environment. Moreover, the Flk-1 upregulation was accompanied by the activation of the phosphoinositide-3 kinase (PI3K)/Akt signaling. We also found that in the presence of the PI3K inhibitor (LY294002), the endothelial commitment of ESCs was abolished, indicating the importance of Akt phosphorylation in the endothelial differentiation of ESCs. Interestingly, in the absence of NO, the activation of Akt phosphorylation alone by using AICT activator (SC-79) did not profoundly promote the endothelial differentiation of ESCs, suggesting an interdependent relationship-between NO and the Akt phosphorylation in driving endothelial fate specification of ESCs. Taken together, we demonstrated that NO releasing in a continuous and controlled manner is a simple and efficient method for directing the endothelial differentiation of ESCs without adding growth factors. Statement of Significance Fascinating data continues to show that artificial stem cell niche not only serve as a physical supporting scaffold for stem cells proliferation, but also as a novel platform for directing stem cell differentiation. Because of the lack of proper microenvironment for generating therapeutic endothelial cells (ECs) in vitro, the source of ECs for transplantation is the major limitation in ECs-based therapy to clinical applications. The current study established a feeder cell-free, 2-dimensional culture system for promoting the differentiation processes of embryonic stem cells (ESCs) committed to the endothelial lineage via using a nitric oxide (NO) controlled releasing hydrogel (CS-NO). Notably, the NO releasing from the hydrogel could selectively up-regulate Flk-1 (early ECs marker) and VE-cadherin (mature ECs marker) in the absence of growth factors, which was of crucial importance in the endothelial differentiation of ESCs. In summary, the current study proposes a simple and efficient method for directing the endothelial differentiation of ESCs without extra growth factors. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Highly Efficient Local Delivery of Endothelial Progenitor Cells Significantly Potentiates Angiogenesis and Full-Thickness Wound Healing.

Chenggui Wang,Qingqing Wang,Wendong Gao,Zengjie Zhang,Yiting Lou,Haiming Jin,Xiaofeng Chen,Bo Lei,Huazi Xu,Cong Mao

DOI: https://doi.org/10.1016/j.actbio.2018.01.019

IF: 10.633

2018-01-01

Acta Biomaterialia

Abstract:Wound therapy with a rapid healing performance remains a critical clinical challenge. Cellular delivery is considered to be a promising approach to improve the efficiency of healing, yet problems such as compromised cell viability and functionality arise due to the inefficient delivery. Here, we report the efficient delivery of endothelial progenitor cells (EPCs) with a bioactive nanofibrous scaffold (composed of collagen and polycaprolactone and bioactive glass nanoparticles, CPB) for enhancing wound healing. Under the stimulation of CPB nanofibrous system, the viability and angiogenic ability of EPCs were significantly enhanced through the activation of Hif-1 alpha/VEGF/SDF-1 alpha signaling. In vivo, CPB/EPC constructs significantly enhanced the formation of high-density blood vessels by greatly upregulating the expressions of Hif-1 alpha, VEGF, and SDF-1 alpha. Moreover, owing to the increased local delivery of cells and fast neovascularization within the wound site, cell proliferative activity, granulation tissue formation, and collagen synthesis and deposition were greatly promoted by CPB/EPC constructs resulting in rapid re-epithelialization and regeneration of skin appendages. As a result, the synergistic enhancement of wound healing was observed from CPB/EPC constructs, which suggests the highly efficient delivery of EPCs. CPB/EPC constructs may become highly competitive cell-based therapeutic products for efficient impaired wound healing application. This study may also provide a novel strategy to develop bioactive cell therapy constructs for angiogenesis-related regenerative medicine. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Enhanced human endothelial progenitor cell adhesion and differentiation by a bioinspired multifunctional nanomatrix

Adinarayana Andukuri,Young-Doug Sohn,Chidinma P Anakwenze,Dong-Jin Lim,Brigitta C Brott,Young-Sup Yoon,Ho-Wook Jun

DOI: https://doi.org/10.1089/ten.TEC.2012.0312

Abstract:Endothelial progenitor cell (EPC)-capturing techniques have led to revolutionary strategies that can improve the performance of cardiovascular implant devices and engineered tissues by enhancing re-endothelialization and angiogenesis. However, these strategies are limited by controversies regarding the phenotypic identities of EPCs as well as their inability to target and prevent the other afflictions associated with current therapies, namely, thrombosis and neointimal hyperplasia. Therefore, the goal of this study was to study the efficacy of a bioinspired multifunctional nanomatrix in recruiting and promoting the differentiation of EPCs toward an endothelial lineage. The bioinspired nanomatrix combines multiple components, including self-assembled peptide amphiphiles (PAs) that include cell adhesive ligands, nitric oxide (NO)-producing donors, and enzyme-mediated degradable sequences to achieve an endothelium-mimicking character. In this study, human peripheral blood mononuclear cells (PBMNCs) were isolated and cultured on the bioinspired multifunctional nanomatrix. Initial cell adhesion, lectin staining, acetylated low-density lipoprotein uptake, and expression of endothelial markers, including CD31, CD34, von Willebrand Factor, and VEGFR2, were analyzed. The results from this study indicate that the NO releasing bioinspired multifunctional nanomatrix promotes initial adhesion of EPCs when compared to control surfaces. The expression of endothelial markers is also increased on the bioinspired multifunctional nanomatrix, suggesting that it directs the differentiation of EPCs toward an endothelial phenotype. The bioinspired nanomatrix therefore provides a novel biomaterial-based platform for capturing as well as directing EPC behavior. Therefore, this study has the potential to positively impact the patency of cardiovascular devices such as stents and vascular grafts as well as enhanced angiogenesis for ischemic or engineered tissues.
Long-term nitric oxide release for rapid endothelialization in expanded polytetrafluoroethylene small-diameter artificial blood vessel grafts

Dongfang Wang,Yiyang Xu,Lixia Wang,Xiaofeng Wang,Shujie Yan,Galip Yilmaz,Qian Li,Lih-Sheng Turng

DOI: https://doi.org/10.1016/j.apsusc.2019.145028

IF: 6.7

2020-03-01

Applied Surface Science

Abstract:Without a complete and confluent endothelial layer covering the luminal surface, expanded polytetrafluoroethylene (ePTFE) small-diameter (<6 mm) artificial blood vessels would fail in vivo due to thrombosis and restenosis. In order to promote rapid endothelialization and anticoagulation, we modified the surface of ePTFE by effectively grafting functional biomolecules, such as nitric oxide (NO) catalyst selenocystamine (SeCA) and vascular endothelial growth factor (VEGF), via dopamine coating. Fourier-transform infrared spectroscopy (FTIR) and X-ray photoelectron spectroscopy (XPS) results showed the successful incorporation of SeCA and VEGF. The release profile of NO, a cell-signaling molecule that regulates cell behavior and platelet aggregation, lasted beyond 35 days and could be controlled by the ratio of SeCA to dopamine. The biological results in terms of cell culture and antithrombogenic properties showed that the surface functionalization strategies promoted human coronary artery endothelial cell (HCAEC) growth and proliferation while preventing platelet adhesion and the formation of thrombi in vitro. A complete endothelial cell monolayer on ePTFE was found to form by day 10. This simple and effective surface functionalization method is beneficial for the eventual clinical application of small-diameter ePTFE blood vessel grafts.

chemistry, physical,physics, applied, condensed matter,materials science, coatings & films
Surface Engineering for Endothelium‐Mimicking Functions to Combat Infection and Thrombosis in Extracorporeal Life Support Technologies

Morgan Ashcraft,Mark Garren,Orsolya Lautner‐Csorba,Vicente Pinon,Yi Wu,Dagney Crowley,Joseph Hill,Yeniselis Morales,Robert Bartlett,Elizabeth J. Brisbois,Hitesh Handa

DOI: https://doi.org/10.1002/adhm.202400492

IF: 10

2024-06-26

Advanced Healthcare Materials

Abstract:Blood‐contacting medical devices routinely fail from the cascading effects of biofouling towards infection and thrombosis. Nitric oxide (NO) is an integral part of endothelial homeostasis, maintaining platelet quiescence and facilitating oxidative/nitrosative stress against pathogens. Recently, it has been shown that the surface evolution of NO can mediate cell‐cell interactions. However, this technique alone cannot prevent the biofouling inherent in device failure with dynamic blood‐contacting applications. In this work, we propose an endothelium‐mimicking surface design pairing controlled NO release with an inherently antifouling polyethylene glycol interface (NO+PEG). This simple, robust, and scalable platform develops surface‐localized NO availability with surface hydration, leading to a significant reduction in protein adsorption as well as bacteria/platelet adhesion. Further in vivo thrombogenicity studies show a decrease in thrombus formation on NO+PEG interfaces, with preservation of circulating platelet and white blood cell counts, maintenance of activated clotting time, and reduced coagulation cascade activation. It is anticipated that this bio‐inspired surface design will enable a facile alternative to existing surface technologies to address clinical manifestations of infection and thrombosis in dynamic blood‐contacting environments. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Co-immobilization of CD133 Antibodies, Vascular Endothelial Growth Factors, and REDV Peptide Promotes Capture, Proliferation, and Differentiation of Endothelial Progenitor Cells.

Yiyuan Duan,Shan Yu,Peifang Xu,Xuemei Wang,Xue Feng,Zhengwei Mao,Changyou Gao

DOI: https://doi.org/10.1016/j.actbio.2019.07.004

IF: 10.633

2019-01-01

Acta Biomaterialia

Abstract:Capture of endothelial progenitor cells (EPCs) in situ has been considered as a promising strategy for the rapid endothelialization and long-term patency of artificial blood vessels and implant devices. In this study, a CD133+ EPC capture surface was fabricated by grafting CD133 antibody (a more specific EPC surface marker than CD34) and Arg-Glu-Asp-Val (REDV) peptideon the methacrylate-grafted hyaluronic acid (MA-HA) and heparin-hybridized (MA-HA&Heparin) resisting layer. Vascular endothelial growth factor (VEGF) was further conjugated to the immobilized heparin. This engineered surface showed good hemocompatibility and significantly higher ability of capturing CD133+ EPCs from human peripheral blood mononuclear cells (PBMCs) and obviously upregulated the expression of endothelial cell (EC) marker genes of EPCs such as VEGF receptor 2 (VEGFR2), CD31, VE-cadherin, and von Willebrand factor (vWF), facilitating the differentiation of EPCs into ECs. The dramatically enhanced EPC proliferation on this surface was dependent on the integrin-VEGFR synergistic signaling, as ERK1/2 phosphorylation was only significantly enhanced on the REDV and VEGF co-immobilized surface. This study highlights a new surface coating strategy for blood-contact materials based on the specific EPC capturing and rapid endothelialization. STATEMENT OF SIGNIFICANCE: Capture of endothelial progenitor cells (EPCs) in situ is a promising strategy for the rapid endothelialization and long-term patency of artificial blood vessels and scaffolds. More specific capture of EPCs by targeting CD133 rather than CD34 can better reduce the risk of inflammation and restenosis. On the other hand, an appropriate microenvironment for EPC proliferation is equally important for endothelialization, which is rarely considered by the existing EPC capture strategies. In this study, the capture ratio of EPCs was significantly increased by simultaneously grafting CD133 antibody and VEGF on a MA-HA and heparin-hybridized antifouling layer. Further, proliferation of EPCs after capture was significantly promoted by grafting VEGF and REDV peptide through the integrin-VEGFR synergistic signaling. This study highlights a new strategy for the surface coating of blood-contact materials based on specific EPC capture and rapid endothelialization.
Systemic sarcoidosis manifested as unilateral eyelid retraction.

R. Behbehani,K. Nipper,R. Eagle,J. Bilyk

DOI: https://doi.org/10.1001/ARCHOPHT.124.4.599

2006-04-01

A M A Archives of Ophthalmology

Abstract:
Oscillating Magnetic Field Regulates Cell Adherence and Endothelialization Based on Magnetic Nanoparticle-Modified Bacterial Cellulose

Lei Zhang,Feng Wei,Qianqian Bai,Danhong Song,Zhuofan Zheng,Yafei Wang,Xin Liu,AL-Ammari Abdulrahman,Yingxin Bian,Xuran Xu,Chuntao Chen,Hongsong Zhang,Dongping Sun

DOI: https://doi.org/10.1021/acsami.0c17213

2020-11-10

Abstract:Despite the widely explored biomaterial scaffolds in vascular tissue engineering applications lately, no ideal platform has been provided for small diameter synthetic vascular grafts mainly due to the thrombosis issue. Endothelium is the only known completely non-thrombogenic material; so, functional endothelialization onto vascular biomaterials is critical in maintaining the patency of vascular networks. Bacterial cellulose (BC) is a natural biomaterial with superior biocompatibility and appropriate hydrophilicity as potential vascular grafts. In previous studies, surface modification of active peptides such as Arg-Gly-Asp (RGD) sequences onto biomaterials has been proven to achieve accelerated and selective endothelial cell (EC) adhesion. In our study, we demonstrated a new strategy to remotely regulate the adhesion of endothelial cells based on an oscillating magnetic field and achieve successful endothelialization on the modified BC membranes. In details, we synthesized bacterial cellulose (BC), magnetic BC (MBC), and RGD peptide-grafted magnetic BC (RMBC), modified with the HOOC-PEG-COOH-coated iron oxide nanoparticles (PEG-IONs). The endothelial cells were cultured on the three materials under different frequencies of an oscillating magnetic field, including "stationary" (0 Hz), "slow" (0.1 Hz), and "fast" (2 Hz) groups. Compared to BC and MBC membranes, the cells on RMBC membranes generally show better adhesion and proliferation. Meanwhile, the "slow" frequency of a magnetic field promotes this phenomenon on RMBC and achieves endothelialization after culture for 4 days, whereas "fast" inhibits the cellular attachment. Overall, we demonstrate a non-invasive and convenient method to regulate the endothelialization process, with promising applications in vascular tissue engineering.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c17213?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c17213</a>.Synthesis of iron oxide nanospheres without surface coating by the coprecipitation method; cell proliferation and cytotoxicity assays; protocol for measuring the leakage of iron oxide nanoparticles from BC by ICP-MS; TGA and DLS analysis of PEG-IONs; characterizations of iron oxide nanospheres made by the coprecipitation method; tensile mechanical properties of BC, MBC, and RMBC; cell viability after incubation with BC, MBC, and RMBC; extent of iron leakage in a cell culture medium measured by ICP-MS (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c17213/suppl_file/am0c17213_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

materials science, multidisciplinary,nanoscience & nanotechnology
Innovative Substrate Design with Basement Membrane Components for Enhanced Endothelial Cell Function and Endothelization

Yuriy Snyder,Soumen Jana

DOI: https://doi.org/10.1002/adhm.202401150

IF: 10

2024-07-19

Advanced Healthcare Materials

Abstract:Fibroblast cells are cultured on fiber substrates to make a membrane containing basement membrane proteins on its surface to improve endothelization. Then, a novel antigen removal process is used to remove the antigens from the membrane. Endothelial cells are cultured on the membrane and decellularized aortic tissue. The cells on the membrane expressed more markers of cell health. Enhancing endothelial cell growth on small‐diameter vascular grafts produced from decellularized tissues or synthetic substrates is pivotal for preventing thrombosis. While optimized decellularization protocols can preserve the structure and many components of the extracellular matrix (ECM), the process can still lead to the loss of crucial basement membrane proteins, such as laminin, collagen IV, and perlecan, which are pivotal for endothelial cell adherence and functional growth. This loss can result in poor endothelialization and endothelial cell activation causing thrombosis and intimal hyperplasia. To address this, the basement membrane's ECM is emulated on fiber substrates, providing a more physiological environment for endothelial cells. Thus, fibroblasts are cultured on fiber substrates to produce an ECM membrane substrate (EMMS) with basement membrane proteins. The EMMS then underwent antigen removal (AR) treatment to eliminate antigens from the membrane while preserving essential proteins and producing an AR‐treated membrane substrate (AMS). Subsequently, human endothelial cells cultured on the AMS exhibited superior proliferation, nitric oxide production, and increased expression of endothelial markers of quiescence/homeostasis, along with autophagy and antithrombotic factors, compared to those on the decellularized aortic tissue. This strategy showed the potential of pre‐endowing fiber substrates with a basement membrane to enable better endothelization.

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Endothelial nitric oxide synthase as a marker for human endothelial progenitor cells.

Wei Qiao,Lingying Niu,Zhao Liu,Tong Qiao,Changjian Liu

DOI: https://doi.org/10.1620/tjem.221.19

2010-01-01

Abstract:Endothelial progenitor cells (EPCs) have been proposed as a promising tool for therapeutic neovascularization, vascular repair, tumor pathology and tissue engineering, though their identification is still a subject of much discussion. EPCs consist of two different subpopulations, termed endothelial cell (EC)-like cells and endothelial outgrowth cells (EOCs). Both types of EPCs are derived from mononuclear cells, but they have different characteristics. Our aim was to characterize and compare the two types of EPCs to find reliable biological features of EPCs that can be used for identification of EPCs. In this study, human peripheral blood mononuclear cells were isolated by density gradient centrifugation and cultured on fibronectin-coated culture plates. While adherent cells were maintained, EC-like cells appeared within 4-7 days of culture, and EOCs developed after 2-3 weeks of culture. EOCs, which were characterized by high proliferation potential, were able to form capillary tubes on Matrigel, but not EC-like cells, despite the higher concentrations of three angiogenic cytokines, vascular endothelial growth factor, granulocyte colony-stimulating factor, and interleukin 8, in the conditioned medium of EC-like cells. In contrast, endothelial nitric oxide synthase (eNOS) was expressed in both types of EPCs, and both cell types could produce nitric oxide (NO), as judged by measuring the total amounts of nitrites and nitrates in culture media. In conclusion, the expression of eNOS and the production of NO could be used as common biological features to identify EPCs. These findings provide new insights into the identification of EPCs.
The role of eNOS in the migration and proliferation of bone-marrow derived endothelial progenitor cells and in vitro angiogenesis.

Aizhen Lu,Libo Wang,Liling Qian

DOI: https://doi.org/10.1002/cbin.10405

IF: 4.473

2015-01-01

Cell Biology International

Abstract:The role of endothelial nitric oxide synthase (eNOS) in the activities of endothelial progenitor cells (EPCs) including migration, proliferation, and tube formation in vitro was investigated. EPCs were obtained from rat bone mononuclear cells by culturing for 7-10 days in EGM-2MV and identified by their capacity for FITC-UEA-1 binding and acetylated low-density lipoprotein (Dil-ac-LDL) intake using fluorescence microscopy. Migration, proliferation and tube formation activities were assessed in the presence or absence of N-nitro-L-argininemethylester (L-NAME), an eNOS inhibitor. mRNA and protein expression of CXCR4, CXCR7, VEGFR2, and eNOS were detected by real-time PCR and western blotting in the presence or absence of L-NAME. Nitric oxide production was detected by nitrate reductase in the presence or absence of L-NAME. Typical spindle-shaped cells appeared on the 7(th)-10(th) day and confluence reached about 80%. The percentage of FITC-UEA-1 and Dil-ac-LDL double-stained cells was about 85%. Cell migration, proliferation, and tube formation were significantly weakened after eNOS was inhibited (P<0.05), and the expressions of CXCR4 and eNOS were significantly reduced (P<0.05, respectively), but there was little change in CXCR7 and VEGFR2. NO production was dramatically decreased after eNOS was inhibited (P<0.05). In summary, L-NAME significantly reduced the expression of eNOS and NO production by EPCs and inhibited migration, proliferation and tube formation by these cells, suggesting that eNOS affects EPC activities; CXCR4 may be implicated in the action of eNOS.
Electrospun fiber membrane with asymmetric NO release for the differential regulation of cell growth

Shengyu Chen,Fan Jia,Luying Zhao,Fuyu Qiu,Shaohua Jiang,Jian Ji,Guosheng Fu

DOI: https://doi.org/10.1007/s42242-021-00131-w

2021-01-01

Bio-Design and Manufacturing

Abstract:The high incidence of cardiovascular disease has led to significant demand for synthetic vascular grafts in clinical applications. Anti-proliferation drugs are usually loaded into devices to achieve desirable anti-thrombosis effects after implantation. However, the non-selectiveness of these conventional drugs can lead to the failure of blood vessel reconstruction, leading to potential complications in the long term. To address this issue, an asymmetric membrane was constructed through electro-spinning techniques. The bilayer membrane loaded and effectively released nitric oxide (NO), as hoped, from only one side. Due to the short diffusion distance of NO, it exerted negligible effects on the other side of the membrane, thus allowing selective regulation of different cells on both sides. The released NO boosted the growth of endothelial cells (ECs) over smooth muscle cells (SMCs)—while on the side where NO was absent, SMCs grew into multilayers. The overall structure resembled a native blood vessel, with confluent ECs as the inner layer and layers of SMCs to support it. In addition, the membrane preserved the normal function of ECs, and at the same time did not exacerbate inflammatory responses. By preparing this material type that regulates cell behavior differentially, we describe a new method for its application in the cardiovascular field such as for artificial blood vessels. Graphic abstract
Endothelialization and characterization of titanium dioxide-coated gas-exchange membranes for application in the bioartificial lung

Michael Pflaum,Marina Kühn-Kauffeldt,Sabrina Schmeckebier,Daniele Dipresa,Kanchan Chauhan,Bettina Wiegmann,Rolf J Haug,Jochen Schein,Axel Haverich,Sotirios Korossis

DOI: https://doi.org/10.1016/j.actbio.2016.12.017

2017-03-01

Abstract:Fouling on the gas-exchange hollow-fiber membrane (HFM) of extracorporeal membrane oxygenation (ECMO) devices by blood components and pathogens represents the major hurdle to their long-term application in patients with lung deficiency or unstable hemodynamics. Although patients are treated with anticoagulants, deposition of blood proteins onto the membrane surface may still occur after few days, leading to insufficient gas transfer and, consequently, to device failure. The aim of this study was to establish an endothelial cell (EC) monolayer onto the gas-exchange membrane of an ECMO device with a view to developing a hemocompatible bioartificial lung. Poly(4-methyl-1-pentene) (PMP) gas-exchange membranes were coated with titanium dioxide (TiO2), using the pulsed vacuum cathodic arc plasma deposition (PVCAPD) technique, in order to generate a stable interlayer, enabling cell adhesion onto the strongly hydrophobic PMP membrane. The TiO2 coating reduced the oxygen transfer rate (OTR) of the membrane by 22%, and it successfully mediated EC attachment. The adhered ECs formed a confluent monolayer, which retained a non-thrombogenic state and showed cell-to-cell, as well as cell-to-substrate contacts. The established monolayer was able to withstand physiological shear stress and possessed a "self-healing" capacity at areas of induced monolayer disruption. The study demonstrated that the TiO2 coating mediated EC attachment and the establishment of a functional EC monolayer. Statement of significance: Surface endothelialization is considered an effective approach to achieve complete hamocompatibility of blood-contacting devices. Several strategies to enable endothelial cell adhesion onto stents and vascular prostheses have already been described in the literature. However, only few studies investigated the feasibility of establishing an endothelial monolayer onto the gas exchange membrane of ECMO devices, using peptides or proteins that were weakly adsorbed via dip coating techniques. This study demonstrated the effectiveness of an alternative and stable titanium dioxide coating for gas-exchange membranes, which enabled the establishment of a confluent, functional and non-activated endothelial monolayer, while maintaining oxygen permeability.
Epigallocatechin gallate mediated sandwich-like coating for mimicking endothelium with sustained therapeutic nitric oxide generation and heparin release

Bo Zhang,Ruijuan Yao,Cheng Hu,Haoshuang Wu,Kunpeng Liu,Li Yang,Rifang Luo,Yunbing Wang,Manfred F. Maitz

DOI: https://doi.org/10.1016/j.biomaterials.2020.120418

IF: 14

2021-02-01

Biomaterials

Abstract:In-stent restenosis after stenting is generally characterized by an inflammatory response, excessive proliferation of smooth muscle cells, and delayed healing of the endothelium layer. In this study, inspired by catechol/gallol surface chemistry, a sandwich-like layer-by-layer (LBL) coating was developed using chitosan and heparin as polyelectrolytes, along with the embedding of an epigallocatechin gallate/copper (EGCG/Cu) complex. The embedding of EGCG stabilized the coating by various intermolecular interactions in the LBL coating (e.g., π-π stacking, weak intermolecular crosslinking, and enriched hydrogen bonding) and supported the sustained release of the cargo heparin over 90 days. This design enabled a biomimetic endothelium function in terms of the sustained release of heparin and continuous in situ generation of nitric oxide, driven by the catalytic decomposition of endogenous S-nitrostothiols by copper ions. The result showed enhanced durability of anticoagulation and suppressed inflammatory response. Moreover, the "sandwich-like" coating supported the growth of endothelial cells and up-regulated the protein expression of vascular endothelial growth factor, while effectively suppressing the proliferation and migration of smooth muscle cells (SMCs) via the up-regulation of cyclic guanosine monophosphate. Ex vivo and in vivo experiments demonstrated the effectiveness of the sandwich-like coating in preventing thrombosis formation, suppressing the growth of SMCs, reducing the infiltration and activation of inflammatory cells, and ultimately achieving rapid in situ endothelialization. Hence, the EGCG-assisted sandwich-like coating might be used as a robust and versatile surface modification strategy for implantable cardiovascular devices.

engineering, biomedical,materials science, biomaterials
Bioinspired NO Release Coating Enhances Endothelial Cells and Inhibits Smooth Muscle Cells

Sheng-yu Chen,Jing Wang,Fan Jia,Zhi-da Shen,Wen-bin Zhang,You-xiang Wang,Ke-feng Ren,Guo-sheng Fu,Jian Ji

DOI: https://doi.org/10.1039/d1tb01828k

IF: 7.571

2021-01-01

Journal of Materials Chemistry B

Abstract:Thrombus and restenosis after stent implantation are the major complications because traditional drugs such as rapamycin delay the process of endothelialization. Nitric oxide (NO) is mainly produced by endothelial nitric oxide synthase (eNOS) on the membrane of endothelial cells (ECs) in the cardiovascular system and plays an important role in vasomotor function. It strongly inhibits the proliferation of smooth muscle cells (SMCs) and ameliorates endothelial function when ECs get hurt. Inspired by this, introducing NO to traditional stent coating may alleviate endothelial insufficiency caused by rapamycin. Here, we introduced SNAP as the NO donor, mimicking how NO affects in vivo, into rapamycin coating to alleviate endothelial damage while inhibiting SMC proliferation. Through wicking effects, SNAP was absorbed into a hierarchical coating that had an upper porous layer and a dense polymer layer with rapamycin at the bottom. Cells were cultured on the coatings, and it was observed that the injured ECs were restored while the growth of SMCs further diminished. Genome analysis was conducted to further clarify possible signaling pathways: the effect of cell growth attenuated by NO may cause by affecting cell cycle and enhancing inflammation. These findings supported the idea that introducing NO to traditional drug-eluting stents alleviates incomplete endothelialization and further inhibits the stenosis caused by the proliferation of SMCs.
Improved Endothelial Function of Endothelial Cell Monolayer on the Soft Polyelectrolyte Multilayer Film with Matrix-Bound Vascular Endothelial Growth Factor.

Hao Chang,Mi Hu,He Zhang,Ke-feng Ren,Bo-chao Li,Huan Li,Li-mei Wang,Wen-xi Lei,Jian Ji

DOI: https://doi.org/10.1021/acsami.6b01870

IF: 9.5

2016-01-01

ACS Applied Materials & Interfaces

Abstract:Endothelialization on the vascular implants is of great importance for prevention of undesired postimplantation symptoms. However, endothelial dysfunction of regenerated endothelial cell (EC) monolayer has been frequently observed, leading to severe complications, such as neointimal hyperplasia, late thrombosis, and neoatherosclerosis. It has significantly impeded long-term success of the therapy. So far, very little attention has been paid on endothelial function of EC monolayer. Bioinspired by the microenvironment of the endothelium in a blood vessel, this study described a soft polyelectrolyte multilayer film (PEM) through layer-by-layer assembly of poly(l-lysine) (PLL) and hyaluronan (HA). The (PLL/HA) PEM was chemically cross-linked and further incorporated with vascular endothelial growth factor. It demonstrated that this approach could promote EC adhesion and proliferation, further inducing formation of EC monolayer. Further, improved endothelial function of the EC monolayer was achieved as shown with the tighter integrity, higher production of nitric oxide, and expression level of endothelial function related genes, compared to EC monolayers on traditional substrates with high stiffness (e.g., glass, tissue culture polystyrene, and stainless steel). Our findings highlighted the influence of substrate stiffness on endothelial function of EC monolayer, giving a new strategy in the surface design of vascular implants.
Balancing functions of antifouling, nitric oxide release and vascular cell selectivity for enhanced endothelialization of assembled multilayers

Sulei Zhang,Jun Sun,Shuaihang Guo,Yichen Wang,Yuheng Zhang,Jiao Lei,Xiaoli Liu,Hong Chen

DOI: https://doi.org/10.1093/rb/rbae096

2024-08-24

Abstract:Surface endothelialization is a promising way to improve the hemocompatibility of biomaterials. However, current surface endothelialization strategies have limitations. For example, various surface functions are not well balanced, leading to undesirable results, especially when multiple functional components are introduced. In this work, a multifunctional surface was constructed by balancing the functions of antifouling, nitric oxide (NO) release and endothelial cell promotion via layer-by-layer (LBL) self-assembly. Poly(sodium p-styrenesulfonate-co-oligo(ethylene glycol) methacrylate) (negatively charged) and polyethyleneimine (positively charged) were deposited on silicon substrates to construct multilayers by LBL self-assembly. Then, organic selenium, which has a NO-releasing function, and the cell-adhesive peptide Gly-Arg-Glu-Asp-Val-Tyr, which selectively promotes endothelial cells, were introduced on the assembled multilayers. Poly(oligo(ethylene glycol) methacrylate) is a hydrophilic component for antifouling properties, and poly(sodium p-styrenesulfonate) is a heparin analog that provides negative charges. By modulating the contents of poly(oligo(ethylene glycol) methacrylate) and poly(sodium p-styrenesulfonate) in the copolymers, the NO release rates catalyzed by the modified surfaces were regulated. Moreover, the behaviors of endothelial cells and smooth muscle cells on modified surfaces were well controlled. The optimized surface strongly promoted endothelial cells and inhibited smooth muscle cells to achieve endothelialization effectively.
Oxygen-Enriched Osteoinductive Nanoerythrocytes Augment Cell Survival and Osteogenic Differentiation for Bone Regeneration

Chung-Sung Lee,Jiabing Fan,Hee Sook Hwang,Chen Chen,Soyon Kim,Tara Aghaloo,Min Lee

DOI: https://doi.org/10.1021/acs.chemmater.2c00376

IF: 10.508

2022-06-27

Chemistry of Materials

Abstract:Despite three-dimensional biomaterial scaffolds emerging for facilitating tissue remodeling and recovery in tissue engineering, the scaffolds with an insufficient oxygen supply are limited by various concerns, such as their retention, localization, survival, and lineage fate control of post-transplantation of stem cells. Herein, we report oxygen-enriched osteoinductive nanoerythrocytes as a facile biomimetic platform for bone formation, combining the biocompatibility of natural red blood cell membranes with the oxygen-carrying perfluorocarbons and the osteoinductive oxysterols. The resulting nanoerythrocytes exhibit a high capacity for oxygen delivery, improving cell survival and proliferation and mitigating hypoxic stress in cell-laden hydrogels as a three-dimensional biomaterial device in vitro and in vivo. Notably, the introduction of oxysterols incites the osteoinductive activity for the differentiation of progenitor cells toward osteogenic lineage through the positive regulation of Hedgehog signaling and in vivo reossification activity against a nonhealing calvarial defect. Given the beneficial properties of the assembled parts in a facile single system, this bioactive and biomimetic nanodelivery system can have the potential to address desired needs in the biomaterial scaffolds for cell delivery and bone tissue engineering.

materials science, multidisciplinary,chemistry, physical
Experimental Study of Recombinant Aukaryotic Expression Vector of Human Enos in ECV304 Cells

T Qiao,QJ Liu,F Ran,L Han,L Zhang,L Li

DOI: https://doi.org/10.4414/smw.2006.10910

2006-01-01

Abstract:Background and purpose: Gene transfer with recombinant non-viral vectors encoding vasodilator proteins, Such as endothelial nitric oxide synthase (eNOS), may be a preferential choice in gene therapy of artery restenosis following angioplasty, stent or anastomosis. However, the transfection rate of a non-viral vector, the harmful effects of eNOS transfection on endothelial cells (EC)and the control release of nitric oxide (NO) have been controversial. We designed the eukaryotic expression vector pcDNA3.1-eNOS to study the regulated expression of eNOS (in the presence of various chemical agents) and to evaluate the exogenous NO effect on EC proliferation in vitro.Methods: The full-length human eNOS cDNA was inserted into the EcoRI cloning site of the pcDNA3.1 expression plasmid and the eNOS direction was tested by restriction enzyme digestion with XhoI to construct recombinant pcDNA3.1-eNOS. After co-transfection of pcDNA3.1-eNOS with pcDNA3.0-EGFP mediated by cationic liposomes into Human umbilical vein endothelial cells (ECV304), the transfection rate and the effect on ECV304 proliferation were calculated by fluorescence microscopy and flowcytometry. eNOS mRNA and protein were detected by reverse transcription-PCR (RT-PCR) and immunofluorescence, respectively. The eNOS activity, NO release and changes of the relevant cells growth curve were assessed after treating the transfected cells with four independent factors including ie Ca2+, L-arginine (L-Arg), Ethylene Diamine Tetraacetic Acid (EDTA) and N-nitro-L-arginine methylester (L-NAME). In addition, we examined the nontransfected cells status by isolated sodium nitroprusside (SNP) treatment.Result: eNOS cDNA was inserted into pcDNA3.1 in die proper direction. RT-PCR analysis showed that pcDNA3.1-eNOS transfected cells could express eNOS mRNA. The rate of eNOS transfection was 39.6 +/- 3.4%. Immunofluorescence staining displayed that subcellular localisation of eNOS was most prominent in plasma membrane and per] nuclear regions of the cell. The eNOS activity of eNOS transfected cells had not increased significantly, whereas, in the presence of Call, L-Arg, EDTA, and L-NAME, the eNOS activity was 96.98 +/- 13.47, 32.57 +/- 6.39, 11.63 +/- 3.02, 15.56 +/- 7.34 U/ml respectively and the NO level was 55.34 +/- 11.19, 9.43 +/- 4.51., 2.63 +/- 1.41, 3.73 +/- 1.65 mmol/L, respectively. Meanwhile, die growth curves of EC shifted. SNP also had obvious growth-inhibiting effects on the cells. Together, the ECV304 growth curve went downward in a NO concentration-dependent manner.Conclusion: Eukaryotic expression vector pcDNA3.1-eNOS was constructed successfully with the ability to express human eNOS mRNA and protein in EC effectively. The activity of eNOS in EC could be regulated by certain exogenous factors. Ca2+ was an important factor promoting NO release and excess NO had a cytotoxic effect on EC in vitro. Controlled release of NO in vivo and polygenic measurements might be considered in more clinical gene therapy studies.
Ex vivo evaluation of blood coagulation on endothelial glycocalyx-inspired surfaces using thromboelastography

Yanyi Zang,Jessi R. Vlcek,Jamie Cuchiaro,Ketul C. Popat,Christine S. Olver,Matt J. Kipper,Melissa M. Reynolds

DOI: https://doi.org/10.1007/s44164-021-00001-w

2021-10-29

In vitro models

Abstract:PurposePresent blood-contacting materials have not yet demonstrated to be effective in reducing blood coagulation without causing additional side effects clinically. We have developed an endothelial glycocalyx-inspired biomimetic surface that combines nanotopography, heparin presentation, and nitric oxide (NO)-releasing features. The resulting modified surfaces have already shown promise in reducing unfavorable blood-material interactions using platelet-rich plasma. In this study, the efficacy of modified surfaces for reducing coagulation of human whole blood was measured. In addition, the effects of leached polysaccharides and chemical modification of the modified surfaces were evaluated.MethodsLeached polysaccharides in the incubation solution were detected by a refractive index method to determine the potential influences of these modified surfaces on the blood coagulation observation. Chemical modifications by the nitrosation process on the polysaccharides in the modified surfaces were detected using attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR). Clot formation parameters were measured using thromboelastography (TEG), a clinically relevant technique to evaluate whole blood coagulation.ResultsNo polysaccharides were detected in the heparinized polyelectrolyte multilayer-coated titania nanotube array surface (TiO2NT + PEM) incubation solution; however, polysaccharides were detected from NO-releasing TiO2NT + PEM surface (TiO2NT + PEM + NO) incubation solution both after the nitrosation process and after all NO was released. The structures of thiolated chitosan and heparin were altered by t-butyl nitrite. All heparin-containing surfaces were shown to slow or inhibit clot formation.ConclusionThis study is the first to evaluate these endothelial glycocalyx-inspired surfaces using clinically relevant parameters, as well as proposing potential influences of these modified surfaces on the inhibition of clot formation.

English Else

Letter: Demonstration of reovirus-like particles in intestinal contents of piglets with diarrhoea.

Nitric Oxide Releasing Hydrogel Promotes Endothelial Differentiation of Mouse Embryonic Stem Cells

Highly Efficient Local Delivery of Endothelial Progenitor Cells Significantly Potentiates Angiogenesis and Full-Thickness Wound Healing.

Enhanced human endothelial progenitor cell adhesion and differentiation by a bioinspired multifunctional nanomatrix

Long-term nitric oxide release for rapid endothelialization in expanded polytetrafluoroethylene small-diameter artificial blood vessel grafts

Surface Engineering for Endothelium‐Mimicking Functions to Combat Infection and Thrombosis in Extracorporeal Life Support Technologies

Co-immobilization of CD133 Antibodies, Vascular Endothelial Growth Factors, and REDV Peptide Promotes Capture, Proliferation, and Differentiation of Endothelial Progenitor Cells.

Systemic sarcoidosis manifested as unilateral eyelid retraction.

Oscillating Magnetic Field Regulates Cell Adherence and Endothelialization Based on Magnetic Nanoparticle-Modified Bacterial Cellulose

Innovative Substrate Design with Basement Membrane Components for Enhanced Endothelial Cell Function and Endothelization

Endothelial nitric oxide synthase as a marker for human endothelial progenitor cells.

The role of eNOS in the migration and proliferation of bone-marrow derived endothelial progenitor cells and in vitro angiogenesis.

Electrospun fiber membrane with asymmetric NO release for the differential regulation of cell growth

Endothelialization and characterization of titanium dioxide-coated gas-exchange membranes for application in the bioartificial lung

Epigallocatechin gallate mediated sandwich-like coating for mimicking endothelium with sustained therapeutic nitric oxide generation and heparin release

Bioinspired NO Release Coating Enhances Endothelial Cells and Inhibits Smooth Muscle Cells

Improved Endothelial Function of Endothelial Cell Monolayer on the Soft Polyelectrolyte Multilayer Film with Matrix-Bound Vascular Endothelial Growth Factor.

Balancing functions of antifouling, nitric oxide release and vascular cell selectivity for enhanced endothelialization of assembled multilayers

Oxygen-Enriched Osteoinductive Nanoerythrocytes Augment Cell Survival and Osteogenic Differentiation for Bone Regeneration

Experimental Study of Recombinant Aukaryotic Expression Vector of Human Enos in ECV304 Cells

Ex vivo evaluation of blood coagulation on endothelial glycocalyx-inspired surfaces using thromboelastography